Gabapentin Tablet
Product Images NDC 72162-1530

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 72162-1530). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

Mean Pain Score: This text appears to be a description of a study or evaluation related to pain scores. The text includes information about different treatment options, specifically parkod and gabapentin, at different doses. It also mentions a placebo group. However, without further context or clearer text, it is difficult to provide a more detailed description.*

FDA Label Image

Figure 2 (Image 02)

The text provided seems to be a table or graph related to a study or experiment involving the administration of a medication or treatment called "Gabapentin" for pain relief. The experiment appears to have been conducted over a period of 7 weeks, with a baseline measurement taken at the beginning. The doses of Gabapentin administered were 1800 mg/day and 2400 mg/day. The text includes a pain score scale ranging from 0 to 10, with mean pain scores recorded for each week. Unfortunately, without further context or clearer information, it is challenging to provide a more specific description.*

FDA Label Image

Figure 3 (Image 03)

Not available.*

FDA Label Image

Image-04 (Image 04)

FDA Label Image

Gabapentin Structural Formula (Image 05)

FDA Label Image

Image-09 (Image 09)

FDA Label Image

Label (Lbl721621530)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.